We use cookies for a better user experience. Read our Privacy Policy

I Agree

Blister Pack Pharmaceutical Products Market

Blister Pack Pharmaceutical Products Market (Drug Type: Tablets and Capsules; Manufacturing Process: Cold Forming and Thermoforming; and End Use: Pharmaceuticals, Nutraceuticals and Supplements, and Veterinary Drugs) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Growing Emphasis on Improving Quality of Existing Packaging Alternatives to Aid Market Growth

Blister packaging has emerged as the gold standard packaging alternative by majority of market players operating in the pharmaceutical sector due to which, the global blister pack pharmaceutical products market has witnessed considerable growth over the past couple of decades. This trend is expected to continue in the upcoming decade. In the current day and age, safeguarding the quality of products and protection from external factors are imperative in the packaging space due to which, players operating in the current blister pack pharmaceutical products market are increasingly focusing on innovations to gain a competitive edge in the current market landscape.

A number of packaging solutions is currently being deployed by pharmaceutical companies to improve the shelf life of tablets, pills, and a range of pharmaceutical products, including PCTFE, PVC, and thermoform blisters. The demand for blister pack pharmaceutical products is on the rise, owing to favorable packaging designs and alignment with requirements of the current pharmaceutical packaging industry. At present, major to small-scale players involved in the current pharmaceutical sector are increasingly focusing on incorporating tamper-evident and safe packaging strategies. The type of blister pack pharmaceutical products continues to vary in accord with the nature of drug.

At the back of these factors, along with increasingly compliance with regulatory requirements, the global blister pack pharmaceutical products market is expected to grow significantly during the forecast period.

Request a sample to get extensive insights into the Blister Pack Pharmaceutical Products Market

Market Players Align Product Development Strategies with Current Requirements

In the current blister pack pharmaceutical products market landscape, market players are aiming toward the development of child-resistant packaging formats. The developed regions including North America and Europe are likely to be at the forefront in terms of market share and value owing to the robust regulatory structure and an organized pharmaceutical ecosystem. The rate at which blister pack pharmaceutical products has evolved in these regions over the past few years indicates that several market players operating in the current blister pack pharmaceutical products market are primarily focusing on research and development to produce products that are in line with the requirements of the industry.

At present, market players are also focusing on addressing various challenges related to boosting the shelf life of products, maximizing production efficiency, and catering to barriers across the value chain. Although traditional blister pack pharmaceutical products have gained worldwide acceptance across the pharmaceutical sector, shortcomings in this type of packaging, particularly in hostile conditions, could hamper the growth of the blister pack pharmaceutical products market during the forecast period.

Product Launch and Collaborations to Remain Key Growth Strategies

Players involved in the current blister pack pharmaceutical products market are expected to focus on forging strategic alliances and launching new blister pack pharmaceutical products to gain a competitive edge. Moreover, customization and deployment of new manufacturing techniques to improve quality and performance are expected to remain a key differentiating factor between top tier and lower tier companies. Recent trends indicate a rise in the number of collaborations between market players in the Asia Pacific region and Europe.

For instance, Amcor entered a partnership with GSK and a machine manufacturer in Italy, CAM-Partena, to produce a robust packaging solution that offers optimum protection for products that are highly sensitive to moisture. In 2019, Tekni-Films launched the SBC 240 polyvinylidene chloride (PVDC)-coated PE film that was particularly designed as a cost-efficient alternative to other existing products in the company’s product portfolio. While product launch and collaborations are likely to continue, market players are also anticipated to focus on the choice of materials to develop high-quality products.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Surge in Demand for Multi-compartment Packaging Products amid COVID-19 Pandemic

The COVID-19 pandemic is expected to have a strong impact on the overall growth trajectory of the global blister pack pharmaceutical products market particularly in the first half of the assessment period. Due to the increasing fear and uncertainty pertaining to the nature of the virus and its mode of transmission in the first two quarters of 2020, players involved in the current pharmaceutical sector were compelled to explore most innovative and safe packaging alternatives. The significant rise in the demand for secondary and primary packaging in a range of drug formats, including capsules, syringes, and bottles, among others, is expected to provide a solid boost to the blister pack pharmaceutical products market amid the ongoing COVID-19 pandemic.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Blister Pack Pharmaceutical Products Market

Analysts’ Viewpoint

The global blister pack pharmaceutical products market is expected to expand at a healthy CAGR of 6.7% during the forecast period. The market growth is primarily driven by factors such as growing emphasis on improving quality and performance of existing packaging alternatives, significant rise in research and development expenditure, and entry of new packaging technologies. Market players should focus on product development and forging strategic alliances with players in other regional markets to gain a competitive edge and expand their market share.

Blister Pack Pharmaceutical Products Market: Overview

  • According to Transparency Market Research’s latest report on the global blister pack pharmaceutical products market for the forecast period of 2020-2030, the market is estimated to be driven by rising spending on research and development in the pharma sector coupled with increasing expenditure on healthcare
  • The global blister pack pharmaceutical products market is expected expand by ~1.9x times to current market value with a CAGR of 6.7% during forecast period

Trend of Contract Manufacturing in Pharmaceutical Industry Bolster Market Growth

  • Rising demand for extensive range of pharmaceutical drugs across the globe has pushed pharmaceutical companies to choose contract development manufacturing organization to fulfil end user demand
  • Contract development and manufacturing organizations provide services associated with drug product development, active pharmaceutical ingredient (API) production, and packaging
  • Contract manufacturing has established as best and feasible alternative to in-house development and manufacturing units of pharmaceuticals companies. Leading generic pharma companies operating in the global pharmaceutical market are rapidly increasing their outsourcing activities to reduce complexities of drug manufacturing, product, and packaging cost.
  • The current trend of outsourcing in global pharmaceutical industry has driven the production volume of blister pack pharmaceuticals products. All these factors are likely to escalate the blister pack pharmaceutical products market growth during the forecast period.

Increasing R&D Activities and Spending in Pharma Sector Strengthen Market Growth

  • Leading pharmaceutical companies operating in the global blister pack pharmaceutical products market are continuing to invest heavily in research and development to update and enhance their product pipeline. These companies are spending significantly on product development to retain competitive edge in the market.
  • Furthermore, new era of medicine development and launching of new drugs have led to small size pharmaceutical companies to invest significantly in research and development. Rising research and development spending and activities across small as well as big size pharmaceutical companies is one of the vital factors behind launch of pharmaceutical drugs, especially oral drugs.
  • Increasing spending on such research and development activities is estimated to accelerate the blister pack pharmaceutical products market growth during the forecast period

Asian Countries to Offer Lucrative Growth Opportunities  

  • Asian countries such as India and China are one of the largest providers of generic drugs globally. Pharmaceutical industry in Asia pacific region has witnessed remarkable growth in recent years and this trend is projected to continue over the next few years. This solid market growth is mainly driven by rising spending of middle class group on healthcare, increasing private sector investment in pharmaceutical R&D, and regional government initiatives for manufacturing pharmaceutical ingredients domestically.
  • Furthermore, low production and packaging cost in Asian countries attracts major portion of manufacturers across the globe. Thus, prominent manufacturers of blister pack pharmaceutical products can target highly-potential Asia Pacific region to maximize their sales and profitability margins as well.  

Blister Pack Pharmaceutical Products Market: Key Findings

  • Based on manufacturing process, the thermoforming segment is projected to lead the overall blister pack pharmaceutical products market with more than 3/4th of the market share in 2020. Owing to its ability to pack and seal an extensive range of pharmaceutical tablets and capsules with low manufacturing cost and faster packaging speed, the segment will continue to drive the global blister pack pharmaceutical products market during the forecast period.
  • As per the TMR analysis, pharmaceuticals is expected to be the most lucrative end-use segment for the blister pack pharmaceutical products market. The same segment is generating consistent demand for blister pack pharmaceutical products such as tablets & capsules and anticipated to hold more than 60% share of total market by the end of 2030. 
  • In terms of market share and revenue generation, the Asia Pacific region is anticipated to dominate the global blister pack pharmaceutical products market. Rising manufacturing output and packaging needs from the pharmaceutical industry in Asian countries is expected to offer substantial opportunities during the forecast period.

Blister Pack Pharmaceutical Products Market: Competition Landscape

  • TMR analysed that the global blister pack pharmaceutical products market is highly competitive, owing to new start-ups and entry of local players. This completion among key players is carefully studied based on developments, strategies, and segmental revenue of companies over the past five years.
  • The recent study on blister pack pharmaceutical products market includes profiles of players such as
    • Pfizer Inc
    • GlaxoSmithKline plc
    • Sanofi
    • Roche Holding AG
    • Novartis AG
    • Allergan
    • Johnson & Johnson
    • Merck
    • Sun Pharmaceutical Industries Ltd
    • Cadila Healthcare, etc.
  • TMR differentiated these players as Tier 1, Tier 2 and Tier 3 as per their segmental earnings. Among these players, Pfizer Inc, Roche Holding AG, and Novartis AG have bene identified as Tier 1 players in blister pack pharmaceutical products market. The Tier 2 players are GlaxoSmithKline plc, Johnson & Johnson and Merck. Tier 3 players include Sun Pharmaceutical Industries Ltd, Cadila Healthcare, etc.

Consistent Demand for Pharma Products during COVID-19 Pandemic Drives Market

  • Rapid spread of novel COVID-19 across the continents has disrupted the supply chain of manufacturing industries worldwide, thus impacting the packaging industry. However, pharmaceuticals packaging, especially the blister packaging segment, is witnessing considerable growth, as the demand for generic and branded medicines is on the rise. Consistent demand for pharmaceuticals tablets and capsules during the COVID-19 pandemic is projected to ensure remarkable market growth for blister pack pharmaceutical products in the near future. 
  • Rising COVID-19 cases, especially in American and European countries has created a significant demand for pharmaceuticals products and led pharmaceutical companies to raise theirs production bar. Rising production of medicines simultaneously uplift the demand for pharmaceutical packaging, including blister packaging. All these factors are likely to propel the blister pack pharmaceutical products market growth in the upcoming years.

Blister Pack Pharmaceutical Products Market – Segmentation

The global blister pack pharmaceutical products market has been bifurcated on the basis of drug type, manufacturing process, end use, and region. Each of these segments are analyzed to provide readers with holistic view of the market.

Drug Type

  • Tablets
  • Capsules

Manufacturing Process

  • Cold Forming
  • Thermoforming

End Use

  • Pharmaceuticals
  • Nutraceuticals and Supplements
  • Veterinary Drugs

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa
Blister Pack Pharmaceutical Products Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. TMR Analysis and Recommendations

    1.4. Opportunity Analysis

2. Market Introduction

    2.1. Market Definition

    2.2. Market Taxonomy

3. Market Viewpoint

    3.1. Global Economic Outlook

    3.2. Global Pharmaceutical Market Overview

    3.3. Macro-Economic Factors and Co-relation Analysis

    3.4. Forecast Factors – Relevance and Impact

    3.5. Value Chain Analysis

        3.5.1. Exhaustive List of Active Participants

            3.5.1.1. Raw Material Suppliers

            3.5.1.2. Manufacturers

            3.5.1.3. Distributers/End Users

        3.5.2. Profitability Margins

4. Impact of COVID-19

        4.1.1. Current Statistics and Probable Future Impact

        4.1.2. Current Economic Projection – GDP/GVA and Probable Impact

        4.1.3. Comparison of SAARs and Market Recovery, for Key Countries

        4.1.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries

        4.1.5. Impact of COVID-19 on Blister Pack Pharmaceutical Products Market

5. Blister Pack Pharmaceutical Products Market Analysis

    5.1. Market Value (US$ Mn) and Analysis & Forecast

    5.2. Y-o-Y Growth Projections

    5.3. Absolute $ Opportunity Analysis

6. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Drug Type

    6.1. Section Summary

    6.2. Introduction

        6.2.1. Market share and Basis Points (BPS) Analysis By Drug Type

        6.2.2. Y-o-Y Growth Projections By Drug Type

    6.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

        6.3.1. Tablets

        6.3.2. Capsules

    6.4. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

        6.4.1. Tablets

        6.4.2. Capsules

    6.5. Market Attractiveness Analysis By Drug Type

7. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Manufacturing Process

    7.1. Section Summary

    7.2. Introduction

        7.2.1. Market share and Basis Points (BPS) Analysis By Manufacturing Process

        7.2.2. Y-o-Y Growth Projections By Manufacturing Process

    7.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

        7.3.1. Cold Forming

        7.3.2. Thermoforming

    7.4. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

        7.4.1. Cold Forming

        7.4.2. Thermoforming

    7.5. Market Attractiveness Analysis By Manufacturing Process

8. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By End Use

    8.1. Section Summary

    8.2. Introduction

        8.2.1. Market share and Basis Points (BPS) Analysis By End Use

        8.2.2. Y-o-Y Growth Projections End Use

    8.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

        8.3.1. Pharmaceuticals

        8.3.2. Nutraceuticals and Supplements

        8.3.3. Veterinary Drugs

    8.4. Market Size (US$ Mn) Forecast 2020-2030, By End Use

        8.4.1. Pharmaceuticals

        8.4.2. Nutraceuticals and Supplements

        8.4.3. Veterinary Drugs

    8.5. Market Attractiveness Analysis By End Use

9. Global Blister Pack Pharmaceutical Products Market Analysis and Forecast, By Region

    9.1. Section Summary

    9.2. Introduction

        9.2.1. Market share and Basis Points (BPS) Analysis By Region

        9.2.2. Y-o-Y Growth Projections By Region

    9.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Region

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa (MEA)

    9.4. Market Size (US$ Mn) Forecast 2020-2030 By Region

        9.4.1. North America

        9.4.2. Latin America

        9.4.3. Europe

        9.4.4. Asia Pacific

        9.4.5. Middle East and Africa (MEA)

    9.5. Market Attractiveness Analysis By Region

10. North America Blister Pack Pharmaceutical Products Market Analysis and Forecast

    10.1. Section Summary

    10.2. Introduction

        10.2.1. Market share and Basis Points (BPS) Analysis By Country

        10.2.2. Y-o-Y Growth Projections By Country

    10.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

    10.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

        10.4.1. U.S.

        10.4.2. Canada

    10.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

    10.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

        10.6.1. Tablets

        10.6.2. Capsules

    10.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

    10.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

        10.8.1. Cold Forming

        10.8.2. Thermoforming

    10.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

    10.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

        10.10.1. Pharmaceuticals

        10.10.2. Nutraceuticals and Supplements

        10.10.3. Veterinary Drugs

    10.11. Prominent Trends

11. Latin America Blister Pack Pharmaceutical Products Market Analysis and Forecast

    11.1. Section Summary

    11.2. Introduction

        11.2.1. Market share and Basis Points (BPS) Analysis By Country

        11.2.2. Y-o-Y Growth Projections By Country

    11.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

    11.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

        11.4.1. Brazil

        11.4.2. Mexico

        11.4.3. Argentina

        11.4.4.  Rest of Latin America

    11.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

    11.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

        11.6.1. Tablets

        11.6.2. Capsules

    11.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

    11.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

        11.8.1. Cold Forming

        11.8.2. Thermoforming

    11.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

    11.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

        11.10.1. Pharmaceuticals

        11.10.2. Nutraceuticals and Supplements

        11.10.3. Veterinary Drugs

    11.11. Prominent Trends

12. Europe Blister Pack Pharmaceutical Products Market Analysis and Forecast

    12.1. Section Summary

    12.2. Introduction

        12.2.1. Market share and Basis Points (BPS) Analysis By Country

        12.2.2. Y-o-Y Growth Projections By Country

    12.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

    12.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

        12.4.1. Germany

        12.4.2. Spain

        12.4.3. Italy

        12.4.4. France

        12.4.5. U.K.

        12.4.6. BENELUX

        12.4.7. NORDIC

        12.4.8. Russia

        12.4.9. Poland

        12.4.10. Rest of Europe

    12.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

    12.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

        12.6.1. Tablets

        12.6.2. Capsules

    12.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

    12.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

        12.8.1. Cold Forming

        12.8.2. Thermoforming

    12.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

    12.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

        12.10.1. Pharmaceuticals

        12.10.2. Nutraceuticals and Supplements

        12.10.3. Veterinary Drugs

    12.11. Prominent Trends

13. Asia Pacific Blister Pack Pharmaceutical Products Market Analysis and Forecast

    13.1. Section Summary

    13.2. Introduction

        13.2.1. Market share and Basis Points (BPS) Analysis By Country

        13.2.2. Y-o-Y Growth Projections By Country

    13.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

    13.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

        13.4.1. China

        13.4.2. India

        13.4.3. Japan

        13.4.4. ASEAN

        13.4.5. Australia and New Zealand

        13.4.6. Rest of APAC

    13.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

    13.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

        13.6.1. Tablets

        13.6.2. Capsules

    13.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

    13.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

        13.8.1. Cold Forming

        13.8.2. Thermoforming

    13.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

    13.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

        13.10.1. Pharmaceuticals

        13.10.2. Nutraceuticals and Supplements

        13.10.3. Veterinary Drugs

    13.11. Prominent Trends

14. Middle East and Africa Blister Pack Pharmaceutical Products Market Analysis and Forecast

    14.1. Section Summary

    14.2. Introduction

        14.2.1. Market share and Basis Points (BPS) Analysis By Country

        14.2.2. Y-o-Y Growth Projections By Country

    14.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

    14.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

        14.4.1. GCC countries

        14.4.2. Northern Africa

        14.4.3. South Africa

        14.4.4. Turkey

        14.4.5. Rest of MEA

    14.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

    14.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

        14.6.1. Tablets

        14.6.2. Capsules

    14.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

    14.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

        14.8.1. Cold Forming

        14.8.2. Thermoforming

    14.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

    14.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

        14.10.1. Pharmaceuticals

        14.10.2. Nutraceuticals and Supplements

        14.10.3. Veterinary Drugs

    14.11. Prominent Trends

15. Market Structure Analysis

    15.1. Market Analysis, by Tier of Companies

    15.2. Market Concentration

    15.3. Market Presence Analysis

16. Competitive Landscape

    16.1. Competition Dashboard

    16.2. Company Market Share Analysis

    16.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)

    16.4. Competition Deep Dive

            16.4.1.1. Pfizer Inc

                16.4.1.1.1. Overview

                16.4.1.1.2. Product Portfolio

                16.4.1.1.3. Profitability

                16.4.1.1.4. Sales Footprint

                16.4.1.1.5. Competition Benchmarking

                16.4.1.1.6. Strategy

                    16.4.1.1.6.1. Marketing Strategy

                    16.4.1.1.6.2. Product Strategy

                    16.4.1.1.6.3. Channel Strategy

            16.4.1.2.  GlaxoSmithKline plc

                16.4.1.2.1. Overview

                16.4.1.2.2. Product Portfolio

                16.4.1.2.3. Profitability

                16.4.1.2.4. Sales Footprint

                16.4.1.2.5. Competition Benchmarking

                16.4.1.2.6. Strategy

                    16.4.1.2.6.1. Marketing Strategy

                    16.4.1.2.6.2. Product Strategy

                    16.4.1.2.6.3. Channel Strategy

            16.4.1.3.  Sanofi

                16.4.1.3.1. Overview

                16.4.1.3.2. Product Portfolio

                16.4.1.3.3. Profitability

                16.4.1.3.4. Sales Footprint

                16.4.1.3.5. Competition Benchmarking

                16.4.1.3.6. Strategy

                    16.4.1.3.6.1. Marketing Strategy

                    16.4.1.3.6.2. Product Strategy

                    16.4.1.3.6.3. Channel Strategy

            16.4.1.4. Roche Holding AG

                16.4.1.4.1. Overview

                16.4.1.4.2. Product Portfolio

                16.4.1.4.3. Profitability

                16.4.1.4.4. Sales Footprint

                16.4.1.4.5. Competition Benchmarking

                16.4.1.4.6. Strategy

                    16.4.1.4.6.1. Marketing Strategy

                    16.4.1.4.6.2. Product Strategy

                    16.4.1.4.6.3. Channel Strategy

            16.4.1.5. Novartis AG

                16.4.1.5.1. Overview

                16.4.1.5.2. Product Portfolio

                16.4.1.5.3. Profitability

                16.4.1.5.4. Sales Footprint

                16.4.1.5.5. Competition Benchmarking

                16.4.1.5.6. Strategy

                    16.4.1.5.6.1. Marketing Strategy

                    16.4.1.5.6.2. Product Strategy

                    16.4.1.5.6.3. Channel Strategy

            16.4.1.6. Allergan

                16.4.1.6.1. Overview

                16.4.1.6.2. Product Portfolio

                16.4.1.6.3. Profitability

                16.4.1.6.4. Sales Footprint

                16.4.1.6.5. Competition Benchmarking

                16.4.1.6.6. Strategy

                    16.4.1.6.6.1. Marketing Strategy

                    16.4.1.6.6.2. Product Strategy

                    16.4.1.6.6.3. Channel Strategy

            16.4.1.7. Johnson & Johnson

                16.4.1.7.1. Overview

                16.4.1.7.2. Product Portfolio

                16.4.1.7.3. Profitability

                16.4.1.7.4. Sales Footprint

                16.4.1.7.5. Competition Benchmarking

                16.4.1.7.6. Strategy

                    16.4.1.7.6.1. Marketing Strategy

                    16.4.1.7.6.2. Product Strategy

                    16.4.1.7.6.3. Channel Strategy

            16.4.1.8. Merck

                16.4.1.8.1. Overview

                16.4.1.8.2. Product Portfolio

                16.4.1.8.3. Profitability

                16.4.1.8.4. Sales Footprint

                16.4.1.8.5. Competition Benchmarking

                16.4.1.8.6. Strategy

                    16.4.1.8.6.1. Marketing Strategy

                    16.4.1.8.6.2. Product Strategy

                    16.4.1.8.6.3. Channel Strategy

            16.4.1.9. Sun Pharmaceutical Industries Ltd

                16.4.1.9.1. Overview

                16.4.1.9.2. Product Portfolio

                16.4.1.9.3. Profitability

                16.4.1.9.4. Sales Footprint

                16.4.1.9.5. Competition Benchmarking

                16.4.1.9.6. Strategy

                    16.4.1.9.6.1. Marketing Strategy

                    16.4.1.9.6.2. Product Strategy

                    16.4.1.9.6.3. Channel Strategy

            16.4.1.10. Cadila Healthcare

                16.4.1.10.1. Overview

                16.4.1.10.2. Product Portfolio

                16.4.1.10.3. Profitability

                16.4.1.10.4. Sales Footprint

                16.4.1.10.5. Competition Benchmarking

                16.4.1.10.6. Strategy

                    16.4.1.10.6.1. Marketing Strategy

                    16.4.1.10.6.2. Product Strategy

                    16.4.1.10.6.3. Channel Strategy

17. Assumptions and Acronyms

18. Research Methodology

List of Tables

Table 01: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 02: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 03: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 04: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Region

Table 05: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 06: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 07: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 08: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 09: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 10: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 11: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 12: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 13: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 14: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 15: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 16: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 17: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 18: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 19: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 20: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 21: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 22: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 23: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 24: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country value (US$ Bn) 2015H-2030F, by Drug Type

List of Figures

Figure 01: Global Blister Pack Pharmaceutical Products Market Share by Drug Type (2020E & 2030F)

Figure 02: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Drug Type, 2020E-2028F

Figure 03: Global Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)

Figure 04: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F

Figure 05: Global Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)

Figure 06: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F

Figure 07: Global Blister Pack Pharmaceutical Products Market Share by Region (2020E & 2030F)

Figure 08: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Region, 2020E-2028F

Figure 09: North America Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)

Figure 10: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F

Figure 11: North America Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)

Figure 12: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F

Figure 13: North America Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)

Figure 14: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F

Figure 15: North America Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)

Figure 16: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F

Figure 17: Latin America Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)

Figure 18: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F

Figure 19: Latin America Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)

Figure 20: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F

Figure 21: Latin America Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)

Figure 22: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F

Figure 23: Latin America Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)

Figure 24: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F

Figure 25: Europe Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)

Figure 26: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F

Figure 27: Europe Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)

Figure 28: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F

Figure 29: Europe Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)

Figure 30: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F

Figure 31: Europe Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)

Figure 32: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F

Figure 33: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)

Figure 34: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F

Figure 35: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)

Figure 36: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F

Figure 37: Asia Pacific Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)

Figure 38: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F

Figure 39: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)

Figure 40: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F

Figure 41: MEA Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)

Figure 42: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F

Figure 43: MEA Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)

Figure 44: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F

Figure 45: MEA Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)

Figure 46: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F

Figure 47: MEA Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)

Figure 48: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

938

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved